Locop, Pilar B.
HRN: 00-56-36 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
09/21/2023
PIPERACILLIN + TAZOBACTAM 4.5G (VLS)
09/21/2023
09/27/2023
IVTT
4.5g
Q6
CAP HR
Waiting Final Action
Indication: Empiric Type of Infection: Pneumonia Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes